Daito Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4577.T

Daito Pharmaceutical Co.,Ltd. EBIT Margin for the year ending May 31, 2024: 9.09%

Daito Pharmaceutical Co.,Ltd. EBIT Margin is 9.09% for the year ending May 31, 2024, a -21.37% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.

Daito Pharmaceutical Co.,Ltd. EBIT Margin for the year ending May 31, 2023 was 11.56%, a -23.53% change year over year.
Daito Pharmaceutical Co.,Ltd. EBIT Margin for the year ending May 31, 2022 was 15.11%, a 25.14% change year over year.
Daito Pharmaceutical Co.,Ltd. EBIT Margin for the year ending May 31, 2021 was 12.08%, a -3.09% change year over year.
Daito Pharmaceutical Co.,Ltd. EBIT Margin for the year ending May 31, 2020 was 12.46%, a 10.48% change year over year.

Key data

Date	EBIT Margin	EPS (Basic)	EPS (Diluted)	Shares (Basic, Weighted)

Tokyo Stock Exchange: 4577.T

Daito Pharmaceutical Co.,Ltd.

CEO	Hiroshi Matsumori
IPO Date	March 24, 2010
Location	Japan
Headquarters	326, Yokamachi
Employees	1,070
Sector	Healthcare
Industries Pharmaceuticals Automotive Parts Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Daito Pharmaceutical Co.,Ltd. manufactures and sells pharmaceutical products worldwide. The company offers various active pharmaceutical ingredients and intermediates, prescription drugs, OTC drugs, and home-delivery medicines; formulations in various forms, such as tablets, capsules, troches, granules, and powders; and contract manufacturing services for formulations of medicinal products to pharmaceutical companies. It also sells health food products. The company was formerly known as Daito Corporation and changed its name to Daito Pharmaceutical Co.,Ltd. in 1992. Daito Pharmaceutical Co.,Ltd. was incorporated in 1942 and is headquartered in Toyama, Japan.

Key trends

Past 5 years